Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow
By S. Gronthos, A. Zannettino, S. Hay, S. Shi, S. Graves, Angela Kortesidis, P. Simmons. Journal of Cell Science, 2003
1,057 citations recorded by the source corpus.
Subfields: Cancer Research, Genetics, Molecular Biology
View Paper: https://www.semanticscholar.org/paper/53a071ed0dae63f6d0e4f30cf1e57326c3ba239f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Genetics
In Molecular Biology
Citations in the corpus
- Mesenchymal stromal cells. Biology of adult mesenchymal stem cells: regulation of niche, self-renewal and differentiation (2007, positive): “Negative selection against glycophorin-A, together with selection of strongly Stro-1-positive cells, enriches CFU-Fs in harvested bone marrow cells to a frequency of 1 in 10 [5].”
- Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy (2004, background): “, [47] STRO-1+ VCAM+ 1 in 3 STRO1+ VCAM+ cells • Adherent fibroblastic-like cells (> 50 cells) with occasional cluster of cells (>10–50 cells) • 0.”
- Mesenchymal stem cells: revisiting history, concepts, and assays. (2008, methodology): “Of note, any genuine stem cell within the BM stroma would be clonogenic, but the reverse statement is not valid, as only a fraction of CFU-Fs are multipotent based on in vivo transplantation (Bianco and Robey, 2004; Gronthos et al., 2003).”
- Marrow-isolated adult multilineage inducible (MIAMI) cells, a unique population of postnatal young and old human cells with extensive expansion and differentiation potential (2004, background): “…of primitive adult pluripotent or multipotent stem cells have been described (Young et al., 1998; Pittenger et al., 1999; Conget and Minguell, 1999; D’Ippolito et al., 1999; Colter et al., 2000; Colter et al., 2001; Reyes et al., 2001; Jiang et al., 2002; Hung t al., 2002; Gronthos et al., 2003).”
- Mesenchymal Stem Cells Derived from Dental Tissues vs. Those from Other Sources: Their Biology and Role in Regenerative Medicine (2009, background): “…reported are STRO-1, CD73, CD90, CD105, CD146, Oct4, Nanog, beta2 integrin positive, and CD14, CD34, CD45, and HLA-DR negative expression (Gronthos et al., 2003; Shi and Gronthos, 2003; Miura et al., 2005; Dominici et al., 2006; Battula et al., 2007; Greco et al., 2007; Gronthos and…”